HIV :: Testing delays cause severe AIDS complications, Einstein researchers find

Despite the availability of life-saving antiretroviral treatment, people infected with HIV (human immunodeficiency virus) continue to die and suffer from complications of AIDS, mainly due to delayed diagnosis and initiation of treatment. A researcher at the Albert Einstein College of Medicine of Yeshiva University and colleagues at Yale University have shed light on why this problem persists. They report their findings in the November issue of the journal Medical Care.

HIV :: HIV-TB spreads in Africa, undermines control of world’s 2 deadliest infectious diseases

The largely unnoticed collision of the global epidemics of HIV and tuberculosis (TB) has exploded to create a deadly co-epidemic that is rapidly spreading in sub-Saharan Africa. However, health systems cannot adequately diagnose, treat, or contain the co-epidemic due to unanswered scientific and medical questions, according to a report issued today by The Forum for Collaborative HIV Research and amplified by experts from leading global health organizations.

Imaging :: Economic motivation may affect how often some physicians order imaging studies

Diagnostic imaging has been one of the fastest growing areas of health care in recent years. Some of that increase can be attributed to the availability of improved imaging studies, but whether some imaging utilization may be inappropriate has been an issue of concern. Now a study from the Institute for Technology Assessment in the Massachusetts General Hospital (MGH) Department of Radiology finds that physicians who consistently refer patients to themselves or members of their own specialty for imaging studies, rather than to radiologists, are more likely to order such studies for a variety of medical conditions. The results suggest that economic motivation could underlie some of the excess referrals.

HIV :: HIV patients sicker when seeking care than in the past

It was hoped that as HIV treatment improved and as HIV-related public health initiatives encouraged people to be tested for the disease and seek care, that HIV-infected patients would seek care quickly. Unfortunately, a new study indicates that patients are actually sicker when they begin therapy. The study is published in the November 15 issue of Clinical Infectious Diseases, currently available online.

HIV :: A low prevalence of H pylori in HIV-positive patients

Helicobacter pylori has been extensively studied and proven to be the main cause of chronic gastritis and peptic ulcer in the HIV-negative population. Patients with chronic active gastritis have evidence of H pylori infection in over 90% of cases and in 70-100% of those with peptic ulcer disease. However, the reason for low incidence of H pylori infection in HIV-positive patients was still not very clear.

HIV :: FDA approves Merck’s Isentress, raltegravir tablets for HIV AIDS

Merck & Co., Inc., announced that the U.S. Food and Drug Administration (FDA) granted ISENTRESS TM (raltegravir) tablets accelerated approval for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

HIV :: Enhanced support to AIDS prevention and care programme in north eastern states, India

The Indian Minister of State for Health & Family Welfare, Smt. Panabaka Lakshmi launched the Joint UN Programme on HIV and AIDS Prevention and Care in the North-Eastern States. This is a unique endeavour, which demonstrates a strong partnership between the Government of India, the UN system and the donors, the Governments of Australia and Sweden to improve the quality of and augment response to the HIV epidemic in North-East India.